CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Novartis AG (NOVN) is a Swiss healthcare company incorporated in 1996. The company operates in three main directions: Innovative Medicines, Alcon and Sandoz. The Innovative Medicines division is split in two separate divisions: Novartis Pharmaceuticals and Novartis Oncology. The Sandoz division is engaged in generic pharmaceutical production, whereas the Alcon department develops devices for eye care treatment. The company operates worldwide, with offices and subsidiaries in all key markets. Novartis shares are traded on the SIX Swiss Exchange and the New York Stock Exchange (NYSE). Learn more about the Novartis share price (NOVN) at Capital.com.
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.